戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                                      Carotid-femoral pulse wave velocity (-0.095 +/- 0.043 SD/SD, P =
2                       Measurements of aortic-femoral pulse wave velocity (afPWV; n = 446) and large-
3 nine ratio measure, and a measure of carotid-femoral pulse wave velocity (cf-PWV) and augmentation in
4                                      Carotid-femoral pulse wave velocity (CF-PWV) and brachial and ce
5  outcome, along with blood pressure, carotid-femoral pulse wave velocity (cf-PWV), lipids/lipoprotein
6 2009 and 2012-2013) by measuring the carotid-femoral pulse wave velocity (cf-PWV).
7                                      Carotid-femoral pulse wave velocity (CF-PWV; the gold standard i
8 e evaluated the relationship between carotid femoral pulse wave velocity (cfPWV) and T-cell activatio
9 nts from three metro areas underwent carotid-femoral pulse wave velocity (cfPWV) assessment between 2
10 plitude, mean arterial pressure, and carotid-femoral pulse wave velocity (CFPWV) in 1480 participants
11                                      Carotid-femoral pulse wave velocity (CFPWV) is a heritable measu
12                                      Carotid-femoral pulse wave velocity (cfPWV) is regarded as the g
13 chial arteries (by ultrasonography), carotid-femoral pulse wave velocity (cfPWV), aortic augmentation
14  stiffness: brachial pulse pressure; carotid-femoral pulse wave velocity (CFPWV), which is related di
15  of aortic stiffness as estimated by carotid-femoral pulse wave velocity (cfPWV).
16  conveniently measured compared with carotid-femoral pulse wave velocity (cfPWV).
17 iovascular risk factors, both higher carotid-femoral pulse wave velocity (hazard ratio [HR], 1.32; 95
18 iuretic peptide were associated with carotid-femoral pulse wave velocity (men: partial correlation, 0
19                                      Carotid-femoral pulse wave velocity (P=0.02), central pulse pres
20 ive protein, and arterial stiffness [carotid-femoral pulse wave velocity (PWV) and carotid augmentati
21 econdary outcomes were changes in carotid to femoral pulse wave velocity (PWV) and plasma 8-isoprosta
22   Vascular stiffness was measured by carotid-femoral pulse wave velocity (PWV) and total arterial com
23 ial flow-mediated dilation (FMD) and carotid-femoral pulse wave velocity (PWV) were measured.
24                 The main outcome was carotid-femoral pulse wave velocity (PWV), an established biomar
25 ry flow-mediated vasodilation (FMD), carotid-femoral pulse wave velocity (PWV), and aortic augmentati
26     During 2007 to 2012, we measured carotid-femoral pulse wave velocity (PWV; SphygmoCor apparatus)
27                                   Carotid-to-femoral pulse wave velocity (PWVc-f) was assessed at bas
28 and homocysteine was associated with carotid-femoral pulse wave velocity (r = 0.072, P = 0.036), forw
29 ity derived from arterial tonometry (carotid-femoral pulse wave velocity [CFPWV], forward wave amplit
30 -17 years and arterial stiffness (carotid to femoral pulse wave velocity [PWV]) measured at age 17 ye
31               Arterial stiffness (carotid to femoral pulse wave velocity [PWV]) was measured and peri
32 aluated 2 aortic stiffness measures, carotid-femoral pulse wave velocity and forward pressure wave am
33 ial artery flow-mediated dilatation, carotid-femoral pulse wave velocity and post-ischaemic brachial
34                                      Carotid-femoral pulse wave velocity and radial tonometry-derived
35                                      Carotid femoral pulse wave velocity associated with both urinary
36 adjusted between-group difference in carotid-femoral pulse wave velocity at 12 months.
37  carotid artery wall echodensity and carotid-femoral pulse wave velocity demonstrated no significant
38                                   Carotid to femoral pulse wave velocity showed a significant reducti
39 nge in the weight-loss group, but carotid-to-femoral pulse wave velocity tended to decrease by 0.5 m/
40 r adding systolic blood pressure and carotid-femoral pulse wave velocity to the model, forward pressu
41                                      Carotid-femoral pulse wave velocity was associated with higher w
42 ulse pressure, pulsatility index and carotid-femoral pulse wave velocity were each associated with in
43 um [CAC] score); arterial stiffness (carotid-femoral pulse wave velocity); incident hypertension, dia
44                         Mean (+/-SD) carotid-femoral pulse wave velocity, a measure of central aortic
45 ssure wave, reflected pressure wave, carotid-femoral pulse wave velocity, and carotid-radial pulse wa
46 ar mass, and fractional shortening), carotid-femoral pulse wave velocity, and central retinal arterio
47 sistance, total arterial compliance, carotid-femoral pulse wave velocity, and drug tolerability were
48 omography scan, such as tonometry of carotid femoral pulse wave velocity, bioelectrical impedance ana
49 evaluated carotid pressure and flow, carotid-femoral pulse wave velocity, brain magnetic resonance im
50 :599-608) present repeated measures of aorto-femoral pulse wave velocity, capacitive compliance (C1),
51 rs of subclinical CVD were assessed: carotid-femoral pulse wave velocity, carotid intima media thickn
52 troglycerin-mediated dilation (NMD), carotid-femoral pulse wave velocity, carotid-radial pulse wave v
53  stiffness and pressure pulsatility (carotid-femoral pulse wave velocity, central pulse pressure [CPP
54 sures of arterial stiffness were the carotid femoral pulse wave velocity, forward pressure wave ampli
55 hat arterial stiffness, measured via carotid-femoral pulse wave velocity, has a better predictive val
56  differences between treatment in carotid-to-femoral pulse wave velocity, high-sensitivity C-reactive
57       Aortic stiffening, assessed by carotid-femoral pulse wave velocity, is associated with CKD.
58     We analyzed the primary outcome, carotid-femoral pulse wave velocity, using a linear mixed effect
59                      The mean +/- SD carotid-femoral pulse wave velocity, which reflects central aort
60  cranberry juice consumption reduced carotid femoral pulse wave velocity-a clinically relevant measur
61 nd we assessed arterial stiffness by carotid-femoral pulse wave velocity.
62 ve promoter region of DDB2 gene with carotid-femoral pulse wave velocity.
63                                      Carotid femoral pulse-wave velocity (cfPWV) measured arterial st
64                                      Carotid-femoral pulse-wave velocity was significantly (P<0.001)
65 on measures (central pulse pressure, carotid-femoral pulse-wave velocity, mean arterial pressure, for